Vanguard Personalized Indexing Management, LLC Editas Medicine, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 41,366 shares of EDIT stock, worth $171,255. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,366
Previous 26,601
55.51%
Holding current value
$171,255
Previous $30,000
203.33%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EDIT
# of Institutions
215Shares Held
45.4MCall Options Held
476KPut Options Held
338K-
Black Rock Inc. New York, NY7.78MShares$32.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$29.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$8.13 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.88MShares$7.77 Million0.0% of portfolio
-
State Street Corp Boston, MA1.85MShares$7.65 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $285M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...